Literature DB >> 28902203

Molecular engineering solutions for therapeutic peptide delivery.

Handan Acar1, Jeffrey M Ting, Samanvaya Srivastava, James L LaBelle, Matthew V Tirrell.   

Abstract

Proteins and their interactions in and out of cells must be well-orchestrated for the healthy functioning and regulation of the body. Even the slightest disharmony can cause diseases. Therapeutic peptides are short amino acid sequences (generally considered <50 amino acids) that can naturally mimic the binding interfaces between proteins and thus, influence protein-protein interactions. Because of their fidelity of binding, peptides are a promising next generation of personalized medicines to reinstate biological harmony. Peptides as a group are highly selective, relatively safe, and biocompatible. However, they are also vulnerable to many in vivo pharmacologic barriers limiting their clinical translation. Current advances in molecular, chemical, and nanoparticle engineering are helping to overcome these previously insurmountable obstacles and improve the future of peptides as active and highly selective therapeutics. In this review, we focus on self-assembled vehicles as nanoparticles to carry and protect therapeutic peptides through this journey, and deliver them to the desired tissue.

Mesh:

Substances:

Year:  2017        PMID: 28902203     DOI: 10.1039/c7cs00536a

Source DB:  PubMed          Journal:  Chem Soc Rev        ISSN: 0306-0012            Impact factor:   54.564


  21 in total

Review 1.  Trends in peptide drug discovery.

Authors:  Markus Muttenthaler; Glenn F King; David J Adams; Paul F Alewood
Journal:  Nat Rev Drug Discov       Date:  2021-02-03       Impact factor: 84.694

2.  A lanthanide-peptide-derived bacterium-like nanotheranostic with high tumor-targeting, -imaging and -killing properties.

Authors:  Wangxiao He; Jin Yan; Lijuan Wang; Bo Lei; Peng Hou; Wuyuan Lu; Peter X Ma
Journal:  Biomaterials       Date:  2019-03-21       Impact factor: 12.479

3.  Mechanistic insights into the pH-dependent membrane peptide ATRAM.

Authors:  Vanessa P Nguyen; Loganathan Palanikumar; Stephen J Kennel; Daiane S Alves; Yujie Ye; Jonathan S Wall; Mazin Magzoub; Francisco N Barrera
Journal:  J Control Release       Date:  2019-02-11       Impact factor: 9.776

4.  Lanthanide-doped nanoparticles conjugated with an anti-CD33 antibody and a p53-activating peptide for acute myeloid leukemia therapy.

Authors:  Fan Niu; Jin Yan; Bohan Ma; Shichao Li; Yongping Shao; Pengcheng He; Wanggang Zhang; Wangxiao He; Peter X Ma; Wuyuan Lu
Journal:  Biomaterials       Date:  2018-03-14       Impact factor: 12.479

5.  DNA Dendrons as Agents for Intracellular Delivery.

Authors:  Max E Distler; Michelle H Teplensky; Katherine E Bujold; Caroline D Kusmierz; Michael Evangelopoulos; Chad A Mirkin
Journal:  J Am Chem Soc       Date:  2021-08-19       Impact factor: 16.383

6.  Enzymatic Self-Assembly Confers Exceptionally Strong Synergism with NF-κB Targeting for Selective Necroptosis of Cancer Cells.

Authors:  Jie Zhou; Xuewen Du; Xiaoyi Chen; Jiaqing Wang; Ning Zhou; Difei Wu; Bing Xu
Journal:  J Am Chem Soc       Date:  2018-02-06       Impact factor: 15.419

Review 7.  Automation and data-driven design of polymer therapeutics.

Authors:  Rahul Upadhya; Shashank Kosuri; Matthew Tamasi; Travis A Meyer; Supriya Atta; Michael A Webb; Adam J Gormley
Journal:  Adv Drug Deliv Rev       Date:  2020-11-24       Impact factor: 15.470

8.  An Organometallic Strategy for Cysteine Borylation.

Authors:  Mary A Waddington; Xin Zheng; Julia M Stauber; Elamar Hakim Moully; Hayden R Montgomery; Liban M A Saleh; Petr Král; Alexander M Spokoyny
Journal:  J Am Chem Soc       Date:  2021-06-01       Impact factor: 16.383

9.  Effect of Pollyallylamine on Alcoholdehydrogenase Structure and Activity.

Authors:  Aleksandr L Kim; Egor V Musin; Alexey V Dubrovskii; Sergey A Tikhonenko
Journal:  Polymers (Basel)       Date:  2020-04-06       Impact factor: 4.329

10.  A general-purpose Nanohybrid fabricated by Polymeric Au(I)-peptide precursor to wake the function of Peptide Therapeutics.

Authors:  Jin Yan; Fanpu Ji; Siqi Yan; Weiming You; Fang Ma; Fanni Li; Yinong Huang; Wenjia Liu; Wangxiao He
Journal:  Theranostics       Date:  2020-07-09       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.